Post by Guidechem

【Biopharma News】Once dismissive of the idea, #Roche surprised the #biotech industry with its $1 billion acquisition of #Poseida Therapeutics—a deal catalyzed by fierce competition in the burgeoning field of allogeneic CAR-T therapies. From #Astellas Pharma's strategic investment to tense negotiations over per-share pricing, the story behind this buyout reveals a high-stakes battle for innovation, collaboration, and dominance in cutting-edge #geneediting and #immunotherapy technologies. #Roche #PoseidaTherapeutics #CART #PharmaAcquisition #AstellasPharma #PiggyBac #CasCLOVER #HealthcareInnovation #AllogeneicTherapies #Biopharma #PharmaceuticalIndustry #ClinicalTrials